I know this is really left field but given nothing is happening on the Frag X front, is there a chance that Neuren could pay Acadia for the rights to Fragile X for 2591, with a restraining provision for application in Trof?
I know it's really left field but the talk of delay from Acadia and whether Neuren should continue with the SBB got me wondering. What are the chances?
Ann: DAYBUE (trofinetide) 2024 net sales US$348 million, page-28
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1657 | $12.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.85 | 6303 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |